R & D Center
The company mainly focuses on the comprehensive development and utilization of bitter bile biological resources to carry out related research and application work, self-built 1500 square meters research and development center and 500 square meters pilot workshop, with nearly 60 technical research and development personnel. It mainly focuses on the extraction and separation, transformation, application and product development of the effective value components of bitter bile, so as to realize the comprehensive development and application of bitter bile resources. The company's products mainly cover two major areas of biomedicine and animal health care.
Adhering to the concept of innovation, the company has maintained long-term cooperation with the team of Academician Qiu Guanzhou of Central South University, carried out technical project development with a number of research institutions, and achieved a number of technical achievements. The company has 14 domestic invention patents, 3 international invention patents, and a number of invention patents have entered the trial, and won the national intellectual property advantage enterprise in 23 years.
Significant progress has been made in the source of ursodeoxycholic acid raw materials and synthetic technology innovation, bilirubin hydrolysis technology and industrial scale, industrial chain intelligent manufacturing. It broke through the "stuck neck" technology that bilirubin cannot achieve mass production, and took the lead in realizing large-scale industrial production of bilirubin. The company has passed a number of provincial-level scientific and technological achievements appraisal, and related projects are at the domestic leading level in the field of similar product development and production. The company's core product ursodeoxycholic acid market share has ranked first in the country.
The company will focus on the whole process of upstream biological resource control, product technology research and development, product intelligent manufacturing and terminal product sales service, and is committed to becoming a "unicorn" enterprise in the whole industry chain, large-scale and digital industry in the field of animal bile resources.
